Oncomed pharmaceuticals inc (OMED)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Operating activities
Net loss

-8,101

-39,062

-103,102

-

-

-

-

-

Net loss

-

-

-

-85,407

-50,010

-26,071

-22,235

-15,034

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,691

1,710

1,764

1,643

1,430

1,378

1,407

1,174

Gain on disposal of equipment

-

-

-

-

113

-

-

-

Stock-based compensation

6,842

9,414

11,131

10,766

6,194

1,736

-

-

Stock-based compensation

-

-

-

-

-

-

836

846

Revaluation of convertible preferred stock warrant liability

-

-

-

-

-

280

17

11

Prepaid convertible preferred stock warrant expense

-

-

-

-

-

17

5

22

Amortization of discount on short-term investments

-

-

-

-

-

-

112

232

Changes in operating assets and liabilities:
Accounts receivable and other receivables

19

-2,110

-68,184

70,657

-2

-

-

-

Receivable-related parties

-

-

-

-

-

-4,000

4,023

-9,000

Income tax refund receivable

-

1,098

-

-7,102

7,102

-

-

-

Prepaid and other current assets

204

-786

-782

1,577

372

229

540

-770

Other assets

-1,114

-684

-379

-121

781

1,096

2,871

20

Deferred tax assets

-

-

-

-

-10,331

10,331

-

-

Accounts payable

-778

-2,325

-1,770

2,212

-1,323

4,907

-2,562

594

Accrued liabilities, income tax payable and other liabilities

318

-4,572

-3,115

-

-

-

-

-

Accrued liabilities and income tax payable

-

-

-

3,662

-

-

-

-

Accrued liabilities

-

-

-

-

-176

6,293

-622

730

Accrued clinical liabilities

-1,698

-17,420

9,633

5,392

3,864

1,609

-

-

Deferred revenue

-44,421

-36,045

-21,272

-

-

-

-

-

Deferred revenue

-

-

-

52,284

-35,059

151,884

-2,165

-9,861

Deferred rent

394

848

450

-679

-624

-541

-446

736

Income tax payable

-

-

-

-

-10,758

10,758

-

-

Net cash used in operating activities

-

-

-

-75,138

-84,497

144,594

-

-

Net cash used in operating activities

-44,862

-84,970

-36,936

-

-

-

-33,345

-11,286

Investing activities
Purchases of property and equipment

655

585

1,158

1,364

1,809

557

714

2,247

Proceeds from sale of equipment

-

-

-

-

30

-

-

-

Purchases of short-term investments

82,305

127,376

207,283

128,806

436,856

132,537

73,939

103,879

Maturities of short-term investments

124,142

185,211

178,738

213,836

340,257

75,250

112,666

113,533

Net cash provided by (used in) investing activities

41,182

57,250

-29,703

-

-

-

38,013

7,407

Financing activities
Proceeds from issuance of common stock related to the exercise of options and employee stock plan purchases

89

2,343

1,239

1,778

2,082

250

156

22

Net cash provided by investing activities

-

-

-

83,666

-98,378

-57,844

-

-

Proceeds from issuance of common stock upon initial public offering, net

-

-

-

-

-

85,149

-

-

Net proceeds from issuance of common stock

-

-

-

-

-

20,519

-

-

Net cash provided by financing activities

-

-

-

1,778

2,082

105,918

-

-

Cash paid for income taxes, net

-

-

-

-

8,200

-

-

-

Repayments on notes payable

-

-

-

-

-

-

346

703

Net cash provided by financing activities

89

4,044

65,148

-

-

-

-190

-681

Net decrease in cash and cash equivalents

-3,591

-23,676

-1,491

10,306

-

192,668

4,478

-4,560

Net increase in cash

-

-

-

-

-180,793

-

-

-

Supplemental cash flow information:
Accrued liabilities for purchase of property and equipment

-

173

244

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

3

38

Conversion of preferred stock warrants to common stock warrants

-

-

-

-

-

462

-

-

At-the-Market Offering [Member]
Net proceeds from issuance of common stock

-

1,701

4,739

-

-

-

-

-

Public Offering [Member]
Net proceeds from issuance of common stock

-

-

59,170

-

-

-

-

-